Cargando…

Physiologically-Relevant Cellular Models for Biomarkers and Drug Discovery

Detalles Bibliográficos
Autor principal:	Jeffrey, Araceli Espinosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412170/ https://www.ncbi.nlm.nih.gov/pubmed/34485994

Ejemplares similares

Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
por: Remus, Jennifer L., et al.
Publicado: (2016)

AI in drug discovery and its clinical relevance
por: Qureshi, Rizwan, et al.
Publicado: (2023)

Cellular and Physiological Effects of Anthrax Exotoxin and Its Relevance to Disease
por: Lowe, David E., et al.
Publicado: (2012)

Lytic Release of Cellular ATP: Physiological Relevance and Therapeutic Applications
por: Grygorczyk, Ryszard, et al.
Publicado: (2021)

Functional patient-derived cellular models for neuropsychiatric drug discovery
por: Lago, Santiago G., et al.
Publicado: (2021)

Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma
por: Utnes, Peter, et al.
Publicado: (2019)

Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
por: Jones, HM, et al.
Publicado: (2013)

Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
por: Shaik, Abdul Naveed, et al.
Publicado: (2019)

Metabolomics and Biomarkers for Drug Discovery
por: Yeung, Pollen K.
Publicado: (2018)

Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy
por: Ponte-Sucre, Alicia
Publicado: (2003)

Glyco-biomarkers: Potential Determinants of Cellular Physiology and Pathology
por: Alavi, Azita, et al.
Publicado: (2008)

Recent Advances in Drug Design and Drug Discovery for Androgen-Dependent Diseases
por: Cabeza, Marisa, et al.
Publicado: (2016)

Prediction of the P. falciparum Target Space Relevant to Malaria Drug Discovery
por: Spitzmüller, Andreas, et al.
Publicado: (2013)

Physiological Discoveries
por: Todd, T. J.
Publicado: (1837)

Protein biomarker discovery is still relevant and has entered a new phase
por: van der Burgt, Yuri E.M.
Publicado: (2019)

Editorial: Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery
por: Rižner, Tea Lanišnik
Publicado: (2019)

Bottom-Up Approach to the Discovery of Clinically Relevant Biomarker Genes: The Case of Colorectal Cancer
por: Kamel, Faddy, et al.
Publicado: (2022)

Aptamer-Based Detection of Disease Biomarkers in Mouse Models for Chagas Drug Discovery
por: de Araujo, Fernanda Fortes, et al.
Publicado: (2015)

Aging Biomarkers for Clinical Trials and Drug Discovery
por: Meer, Margarita, et al.
Publicado: (2021)

Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery
por: Taltynov, Oliver, et al.
Publicado: (2012)

Discovery of clinically relevant fusions in pediatric cancer
por: LaHaye, Stephanie, et al.
Publicado: (2021)

Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens
por: Clausse, Victor, et al.
Publicado: (2019)

High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery
por: Yang, Xiaonan, et al.
Publicado: (2020)

Computational Models for Transplant Biomarker Discovery
por: Wang, Anyou, et al.
Publicado: (2015)

In-depth characterization of a mouse model of post-traumatic epilepsy for biomarker and drug discovery
por: Di Sapia, Rossella, et al.
Publicado: (2021)

Sensitivity analysis of a strongly-coupled human-based electromechanical cardiac model: Effect of mechanical parameters on physiologically relevant biomarkers
por: Levrero-Florencio, F., et al.
Publicado: (2020)

Reverse Epidemiology: An Experimental Framework to Drive Leishmania Biomarker Discovery in situ by Functional Genetic Screening Using Relevant Animal Models
por: Piel, Laura, et al.
Publicado: (2018)

The Relevance of Bioinformatics Applications in the Discovery of Vaccine Candidates and Potential Drugs for COVID-19 Treatment
por: Chukwudozie, Onyeka S, et al.
Publicado: (2021)

Proteomics Applications in Health: Biomarker and Drug Discovery and Food Industry
por: Amiri-Dashatan, Nasrin, et al.
Publicado: (2018)

Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives
por: Andreol, Federico, et al.
Publicado: (2013)

Technical Feasibility and Physiological Relevance of Hypoxic Cell Culture Models
por: Pavlacky, Jiri, et al.
Publicado: (2020)

In Vitro Strategies to Vascularize 3D Physiologically Relevant Models
por: Dellaquila, Alessandra, et al.
Publicado: (2021)

Allometric Scaling of physiologically-relevant organoids
por: Magliaro, Chiara, et al.
Publicado: (2019)

Complement regulation: physiology and disease relevance
por: Cho, Heeyeon
Publicado: (2015)

Cellularizing hydrogel-based scaffolds to repair bone tissue: How to create a physiologically relevant micro-environment?
por: Maisani, Mathieu, et al.
Publicado: (2017)

Cellular physiology and biochemistry
por: McElroy, William D.
Publicado: (1961)

Embedding of Genes Using Cancer Gene Expression Data: Biological Relevance and Potential Application on Biomarker Discovery
por: Choy, Chi Tung, et al.
Publicado: (2019)

The Proteomics Big Challenge for Biomarkers and New Drug-Targets Discovery
por: Savino, Rocco, et al.
Publicado: (2012)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
por: Hedl, Thomas J., et al.
Publicado: (2019)

Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery
por: Honoré, Bent, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ped3ofkgep1mmfd82gdi7qkei2